UK-listed Hikma Pharma has filed a response to the FDA that it hopes will clear the way for approval of its generic of GlaxoSmithKline’s blockbuster respiratory drug Advair. Hikma has been struggling ...

MONDAY, Aug. 7, 2023 (HealthDay News) -- For patients with chronic obstructive pulmonary disease (COPD), generic and brand-name fluticasone-salmeterol are similarly effective and safe, according to a ...

Advair (fluticasone propionate/salmeterol) is a prescription drug that’s used to treat asthma and chronic obstructive pulmonary disease (COPD). This drug can interact with other medications and some ...

Advair (fluticasone propionate/salmeterol) and Symbicort (budesonide/formoterol) are brand-name prescription medications. They’re approved by the Food and Drug ...

Lannett is seeking the approval of a generic form of Advair Diskus (fluticasone-salmeterol powder) in the U.S. Such an approval would be expected to provide a less-expensive alternative to the ...

The purpose of this review is to discuss the development of Wixela™ Inhub™, a generic equivalent of Advair Diskus ®, a fixed-dose combination of fluticasone propionate/salmeterol powder for oral ...

The share price of Cipla gained 8.3 percent intraday on April 3 after the pharma company announced the successful completion of Phase-3 clinical study for a generic version of GSK's Advair Diskus. The ...

March 10 (Reuters) - Mylan NV: * MYLAN PHARMACEUTICALS ULC LAUNCHES WIXELA® INHUB® (FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER, USP), THE FIRST AVAILABLE BIOEQUIVALENT ALTERNATIVE TO ...

HERTFORDSHIRE, England and PITTSBURGH, March 10, 2020 /CNW/ -- Mylan Pharmaceuticals ULC today announced the launch of Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), the ...